DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in ...

CRYOPDP is a leading specialty courier providing services for clinical trials, biopharma, and cell & gene therapies.

Headquartered just outside Paris, Cryopdp handles more than 600,000 shipments per year, with customers and patients in over 135 countries. DHL said the acquisition would enhance its capabilities ...

DHL will acquire healthcare logistics provider Cryopdp from Cryoport, according to an announcement March 31. The deal is valued at $195 million. Cryopdp provides temperature-controlled ...

CRYOPDP’s expertise in white-glove courier services, coupled with its operations in 15 countries and handling over 600,000 shipments annually, will be integrated into DHL’s Pharma Specialized Network.

DHL Group already has an established Life Sciences and Healthcare business, contributing over EUR 5 billion in global revenue in 2024. Building on this foundation, the acquisition of CRYOPDP marks ...

Additionally, DHL Group announced the acquisition of CRYOPDP and a strategic partnership with Cryoport to enhance their supply chain services in the life sciences sector. This partnership aims to ...

DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL's capabilities in ...